184 related articles for article (PubMed ID: 17712791)
21. Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients.
Ansell SM; Geyer SM; Maurer MJ; Kurtin PJ; Micallef IN; Stella P; Etzell P; Novak AJ; Erlichman C; Witzig TE
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6056-63. PubMed ID: 17062681
[TBL] [Abstract][Full Text] [Related]
22. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt.
Cowgill KD; Loffredo CA; Eissa SA; Mokhtar N; Abdel-Hamid M; Fahmy A; Strickland GT
Int J Epidemiol; 2004 Oct; 33(5):1034-9. PubMed ID: 15155696
[TBL] [Abstract][Full Text] [Related]
23. Liver dysfunction in patients with acute myelogenous leukemia: studies on patients not infected with hepatitis C virus during intense therapy.
Kawatani T; Tajima F; Ishiga K; Suou T; Kawasaki H
J Med; 1998; 29(1-2):45-56. PubMed ID: 9704292
[TBL] [Abstract][Full Text] [Related]
24. HCV and HGV in B-cell non-Hodgkin's lymphoma.
Ellenrieder V; Weidenbach H; Frickhofen N; Michel D; Prümmer O; Klatt S; Bernas O; Mertens T; Adler G; Beckh K
J Hepatol; 1998 Jan; 28(1):34-9. PubMed ID: 9537861
[TBL] [Abstract][Full Text] [Related]
25. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
26. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
[TBL] [Abstract][Full Text] [Related]
27. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis.
Cao Y; Zhang Y; Wang S; Zou W
Nephrol Dial Transplant; 2009 Sep; 24(9):2745-51. PubMed ID: 19377056
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.
Nieters A; Kallinowski B; Brennan P; Ott M; Maynadié M; Benavente Y; Foretova L; Cocco PL; Staines A; Vornanen M; Whitby D; Boffetta P; Becker N; De Sanjosé S
Gastroenterology; 2006 Dec; 131(6):1879-86. PubMed ID: 17087949
[TBL] [Abstract][Full Text] [Related]
29. CD20-specific antibody-targeted chemotherapy of non-Hodgkin's B-cell lymphoma using calicheamicin-conjugated rituximab.
Dijoseph JF; Dougher MM; Armellino DC; Kalyandrug L; Kunz A; Boghaert ER; Hamann PR; Damle NK
Cancer Immunol Immunother; 2007 Jul; 56(7):1107-17. PubMed ID: 17160682
[TBL] [Abstract][Full Text] [Related]
30. [Rituximab resistance in B-cell lymphoma and its elimination].
Hatake K; Terui Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):548-51. PubMed ID: 19381025
[TBL] [Abstract][Full Text] [Related]
31. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma.
De Renzo A; Perna F; Persico M; Notaro R; Mainolfi C; de Sio I; Ciancia G; Picardi M; Del Vecchio L; Pane F; Rotoli B
Eur J Haematol; 2008 Jul; 81(1):51-7. PubMed ID: 18397390
[TBL] [Abstract][Full Text] [Related]
32. The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy.
Rawal YB; Nuovo GJ; Frambach GE; Porcu P; Baiocchi RA; Magro CM
J Cutan Pathol; 2005 Oct; 32(9):616-21. PubMed ID: 16176299
[TBL] [Abstract][Full Text] [Related]
33. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
35. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; De La Red G; Gil V; López-Guillermo A; Ingelmo M; Font J
J Rheumatol; 2004 Mar; 31(3):495-9. PubMed ID: 14994393
[TBL] [Abstract][Full Text] [Related]
36. Visualizing hepatitis C virus infections in human liver by two-photon microscopy.
Liang Y; Shilagard T; Xiao SY; Snyder N; Lau D; Cicalese L; Weiss H; Vargas G; Lemon SM
Gastroenterology; 2009 Oct; 137(4):1448-58. PubMed ID: 19632233
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C viral infection is not associated with Waldenström's macroglobulinemia.
Leleu X; O'Connor K; Ho AW; Santos DD; Manning R; Xu L; Hatjiharissi E; Moreau AS; Branagan AR; Hunter ZR; Dimmock EA; Soumerai J; Patterson C; Ghobrial I; Treon SP
Am J Hematol; 2007 Jan; 82(1):83-4. PubMed ID: 16955461
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
